ABACUS MEDICINE A/S — Credit Rating and Financial Key Figures

ABACUS MEDICINE A/S (CVR number: 28111576K) is a company from KØBENHAVN. The company reported a net sales of 1817.6 mEUR in 2025, demonstrating a growth of 22.2 % compared to the previous year. The operating profit percentage was at 1.5 % (EBIT: 27.6 mEUR), while net earnings were 7779 kEUR. The profitability of the company measured by Return on Assets (ROA) was 6.7 %, which can be considered decent but Return on Equity (ROE) was 8 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 19.9 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. ABACUS MEDICINE A/S's liquidity measured by quick ratio was 0.3 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.